Skip to main content
SpringerLink
Log in

Anxiolytika und Hypnotika

  • Chapter
Handbuch der Psychopharmakotherapie

  • 2573 Accesses

Auszug

Schon zu Urzeiten gebrauchten menschen natürliche und artifizielle Mittel zur Anxiolyse und als Hypnotika. So ist bekannt, dass schon die Sumerer vor mehr als 7000 Jahren Opium benutzten, wenn vielleicht auch mehr als Analgetikum oder für kultische Handlungen. Die ersten schriftlichen Rezepte des Bierbrauens sind von 3500 v. Chr. auf einem ägyptischen Papyrus überliefert, während die entsprechenden Reinheitsgebote schon aus babylonischer Zeit bekannt sind. Es kann davon ausgegangen werden, dass Bier zwar im Wesentlichen als ein Nahrungsmittel galt, es aber auch wegen seiner anxiolytischen und hypnotischen Eigenschaften geschätzt wurde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Arbilla S, Allen J, Wick A, Langer SZ (1986) High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzo diazepine receptors. Eur J Pharmacol 130: 257–263

    Article  PubMed  CAS  Google Scholar 

  • Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117: 396–400

    Article  PubMed  CAS  Google Scholar 

  • Baldwin DS, Polkinghorn C (2005) Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychopharmacol 8: 293–302

    Article  PubMed  CAS  Google Scholar 

  • Battaglia J (2005) Pharmacological management of acute agitation. Drugs 65: 1207–1222

    Article  PubMed  CAS  Google Scholar 

  • Benavides J, Peny B, Dubois A, Perrault G, Morel E, Zivkovic B, Scatton B (1988) In vivo interaction of zolpidem with centrla benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the ω 1 (BZD1) subtype. J Pharmacol Exp Ther 245: 1033–1041

    PubMed  CAS  Google Scholar 

  • Berman ME, Jones GD, McCloskey MS (2005) The effects of diazepam on human self-aggressive behavior. Psychopharmacology (Berl) 178: 100–106

    Article  CAS  Google Scholar 

  • Bhatnagar S, Sun LM, Raber J, Maren S, Jullus D, Dallman MF (2004) Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav 81: 545–555

    Article  PubMed  CAS  Google Scholar 

  • Birnir B, Tierney ML, Lim M, Cox GB, Gage PW (1997) Nature of the 5′ residue in the M2 domain affects function of the human α1β1 GABAA receptor. Synapse 26: 324–427

    Article  PubMed  CAS  Google Scholar 

  • Boehm SL 2nd, Ponomarev I, Jennings AW et al (2004a) γ-Aminbutypic acid A receptor subunit mutant mice: new perspectives on alcohol actions. Biochem Pharmacol 68: 1581–1602

    Article  PubMed  CAS  Google Scholar 

  • Boehm SL II, Peden L, Harris RA, Blednov YA (2004b) Deletion of the fyn-kinase gene alters sensitivity to GABAergic drugs: dependence on β2/β3 GABAA receptor subunits. J Pharmacol Exp Ther 309: 1154–1159

    Article  PubMed  CAS  Google Scholar 

  • Bonnet U (2003) Moclobemide: therapeutic use and clinical studies. CNS Drug Rev 9: 97–140

    Article  PubMed  CAS  Google Scholar 

  • Bramness JG, Skurtveit S, Morland J (2004) Impairment due to intake of carisoprodol. Drug Alcohol Depend 74: 311–318

    Article  PubMed  CAS  Google Scholar 

  • Brandon NJ, Uren JM, Kittler JT, Wang H, Olsen R, Parker PJ, Moss SJ (1999) Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors. J Neurosci 19: 9228–9234

    PubMed  CAS  Google Scholar 

  • Brandon N, Jovanovic J, Moss S (2002) Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid(A) receptor function and cell surface expression. Pharmacol Ther 94: 113–122

    Article  PubMed  CAS  Google Scholar 

  • Caccia S (2000) Biotransformation of post-clozapine antipsychotics: pharmacological implications. Clin Pharmacokinet 38: 393–414

    Article  PubMed  CAS  Google Scholar 

  • Carta M, Mameli M, Valenzuela CF (2004) Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. J Neurosci 24: 3746–3751

    Article  PubMed  CAS  Google Scholar 

  • Churn SB, Rana A, Lee K, Parsons JT, De Blas A, Delorenzo RJ (2002) Calcium/calmodulin-dependent kinase II phosphorylation of the GABAA receptor α 1 subunit modulates benzodiazepine binding. J Neurochem 82: 1065–1076

    Article  PubMed  CAS  Google Scholar 

  • Davidson JR (2004) Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. J Clin Psychiatry 65(Suppl 5): 29–33

    PubMed  CAS  Google Scholar 

  • Dorow R, Duka T, Holler L, Sauerbrey N (1987) Clinical perspectives of β-carbolines from first studies in humans. Brain Res Bull 19: 319–326

    Article  PubMed  CAS  Google Scholar 

  • DSM-IV-TR (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision. APA, Washington, DC

    Google Scholar 

  • Dunne EL, Moss SJ, Smart TG (1998) Inhibition of GABA receptor function by tyrosine kinase inhibitors and their inactive analogues. Mol Cell Neurosci 12: 300–310

    Article  PubMed  CAS  Google Scholar 

  • Hanchar HJ, Dodson PD, Olsen RW, Otis TS, Wallner M (2005) Alcoholinduced motor impairment caused by increased extrasynaptic GABAA receptor activity. Nature Neurosci 8: 339–345

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F (1999) The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33: 181–214

    Article  PubMed  CAS  Google Scholar 

  • Jin P, Zhang J, Rowe-Teeter C, Yang J, Stuve LL, Fu GK (2004) Cloning and characterization of a GABAA receptorγ2 subunit variant. J Biol Chem 279: 1408–1414

    Article  PubMed  CAS  Google Scholar 

  • Johnston GA, Curtis DR, Beart PM, Game CJ, McCulloch RM, Twitchin B (1975) Cis-and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem 24: 157–160

    Article  PubMed  CAS  Google Scholar 

  • Katzman M (2004) Venlafaxine in the treatment of anxiety disorders. Expert Rev Neurother 4: 371–381

    Article  PubMed  CAS  Google Scholar 

  • Kelley SP, Bratt AM, Hodge CW (2003) Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur J Pharmacol 461: 19–25

    Article  PubMed  CAS  Google Scholar 

  • Kirkness EF, Bovenkerk CF, Ueda T, Turner AJ (1989) Phosphorylation of γ-aminobutyrate (GABA)/benzodiazepine receptors by cyclic AMP-dependent protein kinase. Biochem J 259: 613–616

    PubMed  CAS  Google Scholar 

  • Klein E, Colin V, Stolk J, Lenox RH (1994) Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: volnerability and effect of carbamazepine. Am J Psychiatry 151: 1760–1766

    PubMed  CAS  Google Scholar 

  • McDonald BJ, Amato A, Connolly CN, Benke D, Moss SJ, Smart TG (1998) Adjacent phosphorylation sites on GABAA receptor β subunits determine regulation by cAMP-dependent protein kinase. Nature Neurosci 1: 23–28

    Article  PubMed  CAS  Google Scholar 

  • McKerman RM, Whiting PJ (1996) Which GABA A-receptor subtypes really occur in the brain? Trends Neurosci 19: 139–143

    Article  CAS  Google Scholar 

  • McKernan RM, Rosahl TW, Reynolds DS et al (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α 1 subtype. Nature Neurosci 3: 587–592

    Article  PubMed  CAS  Google Scholar 

  • Mihalek RM, Bowers BJ, Wehner JM, Kralic JE, VanDoren MJ, Morrow AL Homanics GE (2001) GABAA-receptor δ subunit knockout mice have multiple defects in behavioral responses to ethanol. Alcohol Clin Exp Res 25: 1708–1718

    PubMed  CAS  Google Scholar 

  • Mullins CD, Shaya FT, Meng F, Wang J, Harrison D (2005) Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and ctalopram. Pharmacotherapy 25: 660–667

    Article  PubMed  Google Scholar 

  • Munjack DJ, Crocker B, Cabe D et al (1989) Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol 9: 22–27

    Article  PubMed  CAS  Google Scholar 

  • Ninan PT (2001) Pharmacokinetically induced benzodiazepine withdrawal. Psychopharmacol Bull 35: 94–100

    PubMed  CAS  Google Scholar 

  • Nistri A, Sivilotti L (1985) An unusual effect of γ-aminobutyric acid on synaptic transmission of frog tectalneurones in vitro. Br J Pharmacol 85: 917–921

    PubMed  CAS  Google Scholar 

  • Ntais C, Pakos E, Kyzas P, Ioannidis J (2005) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev, CD005063

    Google Scholar 

  • Nutt D, Lawson C (1992) Panic attacks. A neurochemical overview of models and mechanisms. Br J psychiatry 160: 165–178

    Article  PubMed  CAS  Google Scholar 

  • Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998) Increased anxiety of mice lacking the serotonin 1A receptor. Proc. Natl Acad Sci USA 95: 10734–10739

    Article  PubMed  CAS  Google Scholar 

  • Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101: 815–850

    Article  PubMed  CAS  Google Scholar 

  • Pols HJ, Griez E, Zandbergen J (1989) Does buspirone have anxiogenic properties? Lancet 2: 682–683

    Article  PubMed  CAS  Google Scholar 

  • Pritchett DB, Lüddens H, Seeburg PH (1989) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245: 1389–1392

    Article  PubMed  CAS  Google Scholar 

  • Reeves RR, Beddingfield JJ, Mack JE (2004) Carisoprodol withdrawal syndrome. Pharmacotherapy 24: 1804–1806

    Article  PubMed  Google Scholar 

  • Rho JM, Donevan SD, Rogawski MA (1997) Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther 280: 1383–1391

    PubMed  CAS  Google Scholar 

  • Ruano D, Benavides J, Machado A, Vitorica J (1993) Regional differences in the enhancement by GABA of [3H]zolpidem binding to ω 1 sites in rat brain membranes and sections. Brain Res 600: 134–140

    Article  PubMed  CAS  Google Scholar 

  • Rudolph U, Crestani F, Benke D et al (1999) Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes. Nature 401: 796–800

    Article  PubMed  CAS  Google Scholar 

  • Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroen docrinology 28: 139–168

    Article  CAS  Google Scholar 

  • San L, Arranz B, Escobar R (2005) Pharmacological management of acutely agitated schizophrenic patients. Curr Pharm Des 11: 2471–2477

    Article  PubMed  CAS  Google Scholar 

  • Schofield PR, Darlison MG, Fujita N et al (1987) Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family. Nature 328: 221–227

    Article  PubMed  CAS  Google Scholar 

  • Serafini R, Bracamontes J, Steinbach JH (2000) Structural domains of the human GABAA receptor β3 subunit involved in the actions of pentobarbital. J Physiol 524(Pt 3): 649–676

    Article  PubMed  CAS  Google Scholar 

  • Shivers BD, Killisch I, Sprengel R, Sontheimer H, Köhler M, Schofield PR, Seeburg PH (1989) Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron 3: 327–337

    Article  PubMed  CAS  Google Scholar 

  • Sieghart W, Karobath M (1980) Molecular heterogeneity of benzodiazepine receptors. Nature 286: 285–287

    Article  PubMed  CAS  Google Scholar 

  • Sigel E, Stephenson FA, Mamalaki C, Barnard EA (1983) A γ-aminobutyric acid/benzodiazepine receptor complex of bovine cerebral cortex. J Biol Chem 258: 6965–6971

    PubMed  CAS  Google Scholar 

  • Strohle A, Kellner M, Yassouridis A, Holsboer F, Wiedemann K (1998) Effect of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155: 610–612

    PubMed  CAS  Google Scholar 

  • Ströhle A, Riomeo E, di Michele F et al (2003) Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry 60: 161–168

    Article  PubMed  Google Scholar 

  • Study RE, Barker JL (1981) Diazepam and(−)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured centrla neurons. Proc Natl Acad Sci USA 78: 7180–7184

    Article  PubMed  CAS  Google Scholar 

  • Sur C, Fresu L, Howell O, McKerman RM, Atack JR (1999) Autoradiographic localization of α5 subunit-containing GABAA receptors in rat brain. Brain Res 822: 265–270

    Article  PubMed  CAS  Google Scholar 

  • Susman J, Klee B (2005) The role of high-potency benzodiazepines in the treatment of panic disorder. Prim Care Companion J Clin Psychiatry 7: 5–11

    PubMed  Google Scholar 

  • Thompson SA, Whiting PJ, Wafford KA (1996) Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br J Pharmacol 117: 521–527

    PubMed  CAS  Google Scholar 

  • Vasile RG, Bruce SE, Goisman RM, Pagano M, Keller MB (2005) Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety 22(2): 59–67

    Article  PubMed  Google Scholar 

  • Wallner M, Hanchar HJ, Olsen RW (2003) Ethanol enhancesα4β3δ and α6β3δ γ-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 100: 151218–15223

    Article  CAS  Google Scholar 

  • Wetzel H, Benkert O (1988) Lorazepam for treatment of catatonic symptoms and severe psychomotor retardation. Am J Psychiatry 145: 1175–1176

    PubMed  CAS  Google Scholar 

  • Wetzel H, Heuser I, Benkert O (1987) Stupor and affective state: alleviation of psychomotor distur bances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 175: 240–242

    Article  PubMed  CAS  Google Scholar 

  • Wetzel H, Heuser I, Benkert O (1988) Benzodiazepines for catatonic symptoms, stupor, and mutism. Pharmacopsychiatry 21: 394–395

    PubMed  CAS  Google Scholar 

  • Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001) Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 58: 371–377

    Article  PubMed  CAS  Google Scholar 

  • Wieland H, Lüddens H, Seeburg PH (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267: 1426–1429

    PubMed  CAS  Google Scholar 

  • Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12: 1040–1062

    PubMed  CAS  Google Scholar 

  • Zohar J, Westenberg HG (2000) Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403: 39–49

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Hartmut Lüddens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaus Wiedemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Planck-Institut für Psychiatrie, Kraepelinstraße 2-10, 80804, München

    Florian Holsboer

  2. Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule Aachen, Pauwelsstraße 30, 52074, Aachen

    Gerhard Gründer

  3. Ehemals: Psychiatrische Klinik und Poliklinik der Johannes-Gutenberg-Universität Mainz, Untere Zahlbacher Straße 8, 55131, Mainz

    Otto Benkert

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Lüddens, H., Wiedemann, K. (2008). Anxiolytika und Hypnotika. In: Holsboer, F., Gründer, G., Benkert, O. (eds) Handbuch der Psychopharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68748-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68748-1_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20475-6

  • Online ISBN: 978-3-540-68748-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation